You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Programmed Cell Death Receptor Ligand 1 (PD-L1)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Living Conditions After Non-Hodgkin's Lymphoma in France

Not yet recruiting
  • Non-hodgkin's Lymphoma
  • Data collection
  • Questionnaires
  • Dijon, France
    Chu Dijon Bourgogne
Oct 13, 2022

Rheumatoid Arthritis Trial in Poland (CPL409116, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • Bydgoszcz, Poland
  • +6 more
May 10, 2022

Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Dec 5, 2022

Metabolic Syndrome Trial in Houston (Simvastatin, Vytorin, Placebo)

Completed
  • Metabolic Syndrome
  • Houston, Texas
    Baylor College of Medicine
Jul 21, 2022

Relatives and Intensive Care Units Caregivers of Controlled

Recruiting
  • Death, Assisted
  • +2 more
  • Relative section
  • Caregiver section
  • Paris, France
    APHP - Lariboisière hospital - réanimation chirurgicale
Apr 11, 2022

Noncystic Fibrosis Bronchiectasis (NCFB) Trial in Manchester, Belfast (CSL787, Placebo)

Recruiting
  • Noncystic Fibrosis Bronchiectasis (NCFB)
  • CSL787
  • Placebo
  • Manchester, England, United Kingdom
  • +1 more
Jun 9, 2022

Inflammation, Platelets and Sickle Cell Disease

Not yet recruiting
  • Platelet Activation
  • +2 more
  • Blood sampling
  • Toulouse, France
    IUCT-Oncopole University Hospital
Jan 6, 2023

Pancreaticoduodenectomy, Malnutrition, Postoperative Complications Trial in Charlotte, Lugano, Lausanne (Early enteral

Recruiting
  • Pancreaticoduodenectomy
  • +2 more
  • Early enteral nutrition
  • Charlotte, North Carolina
  • +2 more
Dec 12, 2021

Cytomegalovirus (CMV) Infection Trial in Worldwide (Letermovir oral granules, Letermovir tablet, Letermovir intravenous)

Active, not recruiting
  • Cytomegalovirus (CMV) Infection
  • Letermovir oral granules
  • +2 more
  • Duarte, California
  • +39 more
Jan 9, 2023

Generalized Myasthenia Gravis Trial in Phoenix (ALXN1830, Placebo)

Withdrawn
  • Generalized Myasthenia Gravis
  • Phoenix, Arizona
    Clinical Study Site
Feb 2, 2022

Pancreatic Ductal Adenocarcinoma Trial in Shanghai (H101, Tislelizumab, lenvatinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 30, 2022

Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma Trial in Bordeaux (Treatment with vismodegib)

Completed
  • Metastatic Basal Cell Carcinoma
  • Locally Advanced Basal Cell Carcinoma
  • Treatment with vismodegib
  • Bordeaux, France
    Chu de Bordeaux
Aug 17, 2022

Biliary Externalization After Pancreaticoduodenectomy

Completed
  • Postoperative Complications
  • External biliary stent
  • (no location specified)
Jun 14, 2022

Immune Checkpoint Inhibitors in Genitourinary Malignancies

Suspended
  • Carcinoma, Renal Cell
  • Carcinoma, Urothelial
  • Immune cell and CTC detection procedures
  • Durham, North Carolina
    Duke University Medical Center
Nov 11, 2022

Frequency in Fibromyalgia Syndrome

Completed
  • Fibromyalgia
  • ACR 1990 fibromyalgia critters
  • Niğde, Turkey
    BOR Physical medicine and rehabilitaton hospital
Aug 31, 2021

Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • Adaptive Radiotherapy
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 3, 2022

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Prolonged Grief Disorder Trial in New York, Madison (Web Based Therapist Tutorial on Prolonged Grief Disorder Therapy)

Completed
  • Prolonged Grief Disorder
  • Web Based Therapist Tutorial on Prolonged Grief Disorder Therapy
  • New York, New York
  • +1 more
Jul 19, 2022

Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

Completed
  • Bariatric Surgery
  • Placebo
  • +3 more
  • Hvidovre, Denmark
  • +1 more
Jan 31, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic

Terminated
Has Results
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Comorbidities and Risk Score in COVID-19 Patients

Active, not recruiting
  • Covid19
    • Milan, Italy
    • +4 more
    Apr 20, 2021

    NSCLC Trial in Hangzhou (sintilimab, pemetrexed, Carboplatin)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • sintilimab
    • +3 more
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Jul 11, 2022

    Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Pneumovax-23, Prevenar-13)

    Recruiting
    • Pneumococcal Infections
    • Gamma-PN3
    • +3 more
    • Adelaide, South Australia, Australia
      University of Adelaide
    Aug 1, 2023

    Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

    Recruiting
    • Genitourinary Cancer
    • +7 more
    • La Jolla, California
    • +5 more
    Jul 5, 2022

    Breast Cancer Trial in Italy (Anastrozole or Letrozole or Exemestane)

    Active, not recruiting
    • Breast Cancer
    • Anastrozole or Letrozole or Exemestane
    • Casale Monferrato, AL, Italy
    • +73 more
    May 17, 2022